Methadone as social control: Institutionalized stigma and the prospect of recovery

Qualitative Health Research

Volumn 22, Issue 6, 2012, Pages 810-824

  Harris, Julie ^a   McElrath, Karen ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

addiction substance use; health care, users' experiences; recovery; social identity; stigma

Indexed keywords

METHADONE; NARCOTIC AGENT;

ARTICLE; HUMAN; METHODOLOGY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGICAL ASPECT; SOCIAL PSYCHOLOGY; SOCIAL STIGMA;

HUMANS; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREJUDICE; SOCIAL STIGMA;

EID: 84860525662     PISSN: 10497323     EISSN: 15527557     Source Type: Journal    
DOI: 10.1177/1049732311432718     Document Type: Article

References (72)

1. Anstice S., Strike C. J., Brands B.. Supervised methadone consumption: Client issues and stigma. Substance Use and Misuse. 2009 ; 44: 794-808
2. Bao Y.-P., Liu Z. M., Epstein D. H., Du C., Shi J., Lu L.. A meta-analysis of retention in methadone maintenance by dose and dosing strategy. American Journal of Drug and Alcohol Abuse. 2009 ; 35: 28-33
3. Biernacki P. Pathways from heroin addiction: Recovery without treatment. Philadelphia: Temple University Press ; 1986:
4. Bourgois P.. Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry. 2000 ; 24: 165-195
5. Butler S.. The making of the methadone protocol: The Irish system?. Drugs: Education, Prevention and Policy. 2002 ; 9: 311-324
6. Campbell C., Deacon H.. Unravelling the contexts of stigma: From internalization to resistance to change. Journal of Community and Applied Social Psychology. 2006 ; 16: 411-417
7. Central Statistics Office. (2006). Persons, males and females, aged 15 years and over in each province, county and city, classified by labor force, employment status and labor force participation rate. Retrieved from http://census.cso.ie/census/ReportFolders/ReportFolders.aspx
8. Cohen S. Visions of social control: Crime, punishment and classification. Cambridge: Polity ; 1985:
9. Corsi K. F., Lehman W. K., Booth R. E.. The effect of methadone maintenance on positive outcomes for opiate injection drug users. Journal of Substance Abuse Treatment. 2009 ; 37: 120-126
10. Department of Health and Children. (2002). Report of the benzodiazepine committee. Dublin: Author. Retrieved from http://www.dohc.ie/publications/ benzodiazepines-good-practice-guidelines.html
11. Department of Health, Social Services and Public Safety. (2010). Statistics from the Northern Ireland substitute prescribing database: 31 March 2010. Belfast: Author. Retrieved from http://www.dhsspsni.gov.uk/substitute- prescribing-report-2009-10.pdf
12. Des JarlaisD. C.PaoneD.FriedmanS. R.PeyserN.NewmanR. G. (1995). Regulating controversial programs for unpopular people: Methadone maintenance and syringe exchange programs. American Journal of Public Health, 85, 1577-1584. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1615684
13. DoleV. P.NyswanderM. E. (1980). Methadone maintenance: A theoretical perspective. In LettieriD. J.SayersM.PearsonH. W. (Eds.), Theories on drug abuse: Selected contemporary perspectives (pp. 256-261). NIDA Research Monograph 30. Washington, DC: U. S. Government Printing Office. Retrieved from http://archives.drugabuse.gov/ pdf/monographs/download30.html
14. European Monitoring Centre for Drugs and Drug Addiction. (2010). Estimated number of clients in methadone treatment and of all clients receiving any opioid substitution treatment (OST), Table HSR-3. Statistical Bulletin 2010. Lisbon: Author. Retrieved from http://www.emcdda.europa.eu/stats10/hsrtab3b
15. Fareed A., Casarella J., Amar R., Vayalapalli S., Drexler K.. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. Journal of Psychiatric Practice. 2009 ; 15: 227-234
16. Farré M., Mas A., Torrens M., Moreno V., Camí J.. Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis. Drug and Alcohol Dependence. 2002 ; 65: 283-290
17. Fischer B., Rehm J., Kim G., Kirst M.. Eyes wide shut? A conceptual and empirical critique of methadone maintenance treatment. European Addiction Research. 2005 ; 11: 1-14
18. Fountain J., Griffiths P., Farrell M., Gossop M., Strang J. A qualitative study of patterns of prescription drug use amongst chronic drug users. London: Department of Health ; 1996:
19. Fraser S., Valentine K. New York: Palgrave Macmillan ; 2008:
20. FraserS.ValentineK.TreloarC.MacmillanK. (2007). Methadone maintenance treatment in New South Wales and Victoria: Takeaways, diversion and other key issues. Sydney, NSW, Australia: National Centre in HIV Social Research. Retrieved from http://nchsr.arts.unsw.edu.au/media/File/Methadone2007.pdf
21. Fugelstad A., Stenbacka M., Leifman A., Nylander M., Thiblin I.. Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings. Addiction. 2007 ; 102: 406-412
22. Gilmore N., Somerville M. A.. Stigmatization, scapegoating and discrimination in sexually transmitted diseases: Overcoming 'them' and 'us.'. Social Science and Medicine. 1994 ; 39: 1339-1358
23. Goffman E. Stigma: Notes on the management of spoiled identity. Englewood Cliffs, NJ: Prentice-Hall ; 1963:
24. Gowing L., Farrell M., Bornemann R.. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews. 2008 ; ( Issue 2 ):
25. Hammersley M., Atkinson P. Ethnography: Principles in practice. 1995 ). Ethnography: Principles in practice (2nd ed.). London: Routledge. London: Routledge ; 1995:
26. HarrisJ. (2011). Risk and enabling environments: Influences on initiations into injecting drug use and heroin use, transitions to and from injecting drug and patterns of use. Doctoral dissertation, in progress, Queen's University, Belfast.
27. Harris K. A., Arnsten J. H., Joseph H., Hecht J., Marion I., Juliana P., Gourevitch M. N.. A 5-year evaluation of a methadone medical maintenance program. Journal of Substance Abuse Treatment. 2006 ; 31: 433-438
28. HartelD. M.SchoenbaumE. E. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports, 113, 107-115. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC1307733
29. Health Service Executive. (2011). The introduction of the opioid treatment protocol. Dublin, Ireland: Author. Retrieved from www.drugs.ie/pdfs/ 2010/Opioid-Treatment-Protocol.pdf
30. Holt M.. Agency and dependency within treatment: Drug treatment clients negotiating methadone and antidepressants. Social Science and Medicine. 2007 ; 64: 1937-1947
31. Inciardi J. A., Surratt H. L., Cicero T. J., Beard R. A.. Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment. Pain Medicine. 2009 ; 10: 537-548
32. Kellogg S., Melia D., Khuri E., Lin A., Ho A., Kreek M. J.. Adolescent and young adult heroin patients: Drug use and success in methadone maintenance treatment. Journal of Addictive Disease. 2006 ; 25: 15-25
33. Kelly S. M., O'Grady K. E., Brown B. S., Mitchell S. G., Schwartz R. P.. The role of patient satisfaction in methadone treatment. American Journal of Drug and Alcohol Abuse. 2010 ; 36: 150-154
34. Koski A., Ojanperä I., Vuori E.. Alcohol and benzodiazepines in fatal poisonings. Alcoholism: Clinical and Experimental Research. 2002 ; 26: 956-959
35. Lind B., Chen S., Weatherburn D., Mattick R.. The effectiveness of methadone maintenance treatment in controlling crime: An Australian aggregate-level analysis. British Journal of Criminology. 2005 ; 45: 201-211
36. Link B. G., Phelan J. C.. Stigma and its public health implications. Lancet. 2006 ; 367: 528-529
37. Liu E., Liang T., Shen L., Zhong H., Wag B., Wu Z., Detels R.. Correlates of methadone client retention: A prospective cohort study in Guizhou province, China. International Journal of Drug Policy. 2009 ; 20: 304-308
38. Livingston J. D., Boyd J. E.. Correlates and consequences of internalized stigma for people living with mental illness: A systematic review and meta-analysis. Social Science and Medicine. 2010 ; 71: 2150-2161
39. LloydC. (2010). Sinning and sinned against: The stigmatisation of problem drug users. London: UK Drug Policy Commission. Retrieved from www.ukdpc.org.uk/resources/Stigma-Expert-Commentary-final.pdf
40. Luoma J. B., Twohig M. P., Waltz T., Hayes S. C., Roget N., Padilla M., Fisher G.. An investigation of stigma in individuals receiving treatment for substance abuse. Addictive Behaviors. 2007 ; 32: 1331-1346
41. MaguraS.RosenblumA. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine, 68, 62-74. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11135508
42. Mancino M., Curran G., Han X., Allee E., Humphreys K., Booth B. M.. Predictors of attrition from a national sample of methadone maintenance patients. American Journal of Drug and Alcohol Abuse. 2010 ; 36: 155-160
43. Matheson C.. Privacy and stigma in the pharmacy: Illicit drug users' perspectives and implications for pharmacy practice. Pharmaceutical Journal. 1998 ; 260: 639-641
44. Matheson C., Pitcairn J., Bond C. M., van Teijlingen E., Ryan M.. General practice management of illicit drug users in Scotland: A national survey. Addiction. 2003 ; 98: 119-126
45. McElrath K. Dundalk (County Louth, Ireland): Drugs Advisory Group ; 2008:
46. McElrath K. Drug use in Fingal and associated need for support services. Swords (Fingal, Ireland): North Dublin City and County Regional Drugs Task Force ; 2009:
47. McElrathK.JordanM. (2005). Drug use and risk behaviours among injecting drug users. Belfast: Department of Health, Social Services and Public Safety. Retrieved from http://www.dhsspsni.gov.uk/index/stats-research/stats-public- health/stats-drug-alcohol.htm#dacurpubs
48. McElrathK.McEvoyK. (2001). Heroin as evil: Ecstasy users' perceptions about heroin. Drugs: Education, Prevention and Policy, 8, 177-189. Retrieved from www.drugsandalcohol.ie/6876/1/McElrath-4060-Heroin-as-Evil.pdf
49. Miles M. S., Isler M. R., Banks B. B., Sengupta S., Corbie-Smith G.. Silent endurance and profound loneliness: Socioemotional suffering in African Americans living with HIV in the rural south. Qualitative Health Research. 2011 ; 21: 489-501
50. Qualitative Health Research. Mill J. E. Edwards N. Jackson R. C. MacLean L. Chaw-Kent J., ed. 2010: 1469-1483.
51. Newman R. G.. Methadone maintenance: It ain't what it used to be. British Journal of Addiction. 1976 ; 71: 183-186
52. Nosyk B., Marsh D. C., Sun H., Schecter M. T., Anis A. H.. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. Journal of Substance Abuse Treatment. 2010 ; 39: 22-31
53. Opsal T. D.. Women disrupting a marginalized identity: Subverting the parolee identity through narrative. Journal of Contemporary Ethnography. 2011 ; 40: 135-167
54. Parker R., Aggleton P.. HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action. Social Science & Medicine. 2003 ; 57: 13-24
55. Patterson B. L., Backmund M., Hirsch G., Yim C.. The depiction of stigmatization in research about hepatitis C. International Journal of Drug Policy. 2007 ; 18: 364-373
56. Porter J.. The street/treatment barrier: Treatment experiences of Puerto Rican injection drug users. Substance Use and Misuse. 1999 ; 34: 1951-1975
57. Radcliffe P., Stevens A.. Are drug treatment services only for 'thieving junkie scumbags'? Drug users and the management of stigmatised identities. Social Science and Medicine. 2008 ; 67: 1065-1073
58. ReisingerH. S.SchwartzR. P.MitchellS. G.PetersonJ. A.KellyS. M.O'GradyK. E.... AgarM. H. (2009). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs, 41, 285-296. Retrieved from http://www.tandfonline.com/doi/abs/10.1080/02791072.2009.10400539
59. Saris A. J.. An uncertain dominion: Irish psychiatry, methadone and the treatment of opiate abuse. Culture, Medicine and Psychiatry. 2008 ; 32: 259-277
60. SheerinI.GreenT.SellmanD.AdamsonS.DeeringD. (2004). Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. New Zealand Medical Journal, 117, U795. Retrieved from http://www.nzma.org.nz/ journal/117-1190/795/
61. Simmonds L., Coomber R.. Injecting drug users: A stigmatised and stigmatising population. International Journal of Drug Policy. 2009 ; 20: 121-130
62. SimoensS.MathesonC.BondC.InksterK.LudbrookA. (2005). The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. British Journal of General Practice, 55, 139-146. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463190/
63. Stone E., Fletcher K.. User views on supervised methadone consumption. Addiction Biology. 2003 ; 8: 45-48
64. Tanaka E.. Toxicological interactions between alcohol and benzodiazepines. Clinical Toxicology. 2002 ; 40: 69-75
65. Teesson M., Ross J., Darke S., Lynskey M., Ali R., Ritter A., Cooke R.. One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence. 2006 ; 83: 174-180
66. Varas-Díaz N., Serrano-García I., Toro-Alfonso J.. AIDS-related stigma and social interaction: Puerto Ricans living with HIV/AIDS. Qualitative Health Research. 2005 ; 15: 169-187
67. VigilantL. G. (2001). "Liquid handcuffs": The phenomenology of recovery on methadone maintenance. (Doctoral dissertation, Boston College). Retrieved from WorldCat database (OCLC: 48134549).
68. Vigilant L. G.. The stigma paradox in methadone maintenance: Naïve and positive consequences of a "treatment punishment" approach to opiate addiction. Humanity and Society. 2004 ; 28: 403-418
69. Villafranca S. W., McKellar J. D., Trafton J. A., Humphreys K.. Predictors of retention in methadone programs: A signal detection analysis. Drug and Alcohol Dependence. 2006 ; 83: 218-224
70. WhiteW. L. (2010). Long-term strategies to reduce the stigma attached to addiction, treatment, and recovery within the City of Philadelphia (with particular reference to medication-assisted treatment/recovery). Retrieved from http://www.comproviders.com/files/stigma-william-white-101309.pdf
71. Worthington C., Myers T.. Factors underlying anxiety in HIV testing: Risk perceptions, stigma, and the patient-provider power dynamic. Qualitative Health Research. 2003 ; 13: 636-655
72. Yang L. H., Kleinman A., Link B. G., Phelan J. C., Lee S., Good B.. Culture and stigma: Adding moral experience to stigma theory. Social Science & Medicine. 2007 ; 64: 1524-1535